Advances in the diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus

Corresponding author: LI Renfeng， lirenfengdog@126.com （ORCID： 0000-0002-8104-4608）
Received Date: 2024-06-15
Accepted Date: 2024-07-08
Published Date: 2025-02-25

Abstract

Abstract

Hepatocellular carcinoma （HCC） with biliary duct tumor thrombus （BDTT） is currently not common in clinical practice and is easily misdiagnosed， and previously， it was often considered an advanced stage of the disease with a poor prognosis， making its treatment challenging. However， in-depth studies in recent years have gradually deepened our understanding of this disease， leading to significant changes in diagnostic and treatment concepts. Currently， comprehensive treatment， mainly surgery， is used for treatment， but there is still controversy over the selection of clinical treatment strategies. This article provides a detailed discussion on surgical methods and prognosis， in order to provide a reference for clinical treatment options.
- Carcinoma， Hepatocellular,
- Biliary Duct Tumor Thrombus,
- Diagnosis,
- Therapeutics,
- Prognosis

FullText(HTML)

References(39)

References

[1]	SIEGEL R, MILLER KD, WAGLE NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73: 17- 48. DOI: 10.3322/caac.21763.
[2]	SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71( 3): 209- 249. DOI: 10.3322/caac.21660.
[3]	FENG JK, CHEN ZH, SUN JX, et al. Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: A propensity score matching analysis[J]. Ann Transl Med, 2021, 9( 6): 457. DOI: 10.21037/atm-20-6449.
[4]	DONG W, ZHANG T, WANG ZG, et al. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis[J]. World J Gastroenterol, 2014, 20( 29): 10174- 10182. DOI: 10.3748/wjg.v20.i29.10174.
[5]	YANG X, QIU Z, RAN R, et al. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis[J]. Oncol Lett, 2018, 16( 3): 3593- 3602. DOI: 10.3892/ol.2018.9108.
[6]	JIN Q, YU YB, JIANG B, et al. Progress in diagnosis and treatment of hepatocellular carcinoma with cancer thrombus in bile duct[J]. Med Recapitulate, 2020, 26( 16): 3201- 3205. DOI: 10.3969/j.issn.1006-2084.2020.16.015. 金铨, 禹亚彬, 蒋彬, 等. 肝细胞肝癌合并胆管癌栓的诊疗进展[J]. 医学综述, 2020, 26( 16): 3201- 3205. DOI: 10.3969/j.issn.1006-2084.2020.16.015.
[7]	ZHOU D, HU GF, GAO WC, et al. Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion[J]. World J Gastroenterol, 2020, 26( 44): 7005- 7021. DOI: 10.3748/wjg.v26.i44.7005.
[8]	CONTICCHIO M, MAGGIALETTI N, RESCIGNO M, et al. Hepatocellular carcinoma with bile duct tumor thrombus: A case report and literature review of 890 patients affected by uncommon primary liver tumor presentation[J]. J Clin Med, 2023, 12( 2): 423. DOI: 10.3390/jcm12020423.
[9]	YANG XW, RAN RZ, DU J, et al. CCL20 is overexpressed in hepatocellular carcinoma with bile duct tumor thrombus and correlates negatively with surgical outcome[J]. Int J Clin Exp Pathol, 2018, 11( 8): 3977- 3983.
[10]	XU LB, QIN YF, SU LP, et al. Cathepsin-facilitated invasion of BMI1-high hepatocellular carcinoma cells drives bile duct tumor thrombi formation[J]. Nat Commun, 2023, 14( 1): 7033. DOI: 10.1038/s41467-023-42930-y.
[11]	Chinese Association of Liver Cancer and Chinese Medical Doctor Association. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus(2020)[J]. Chin J Pract Surg, 2021, 41( 3): 241- 247. DOI: 10.19538/j.cjps.issn1005-2208.2021.03.01. 中国医师协会肝癌专业委员会. 肝细胞癌合并胆管癌栓多学科诊治中国专家共识(2020版)[J]. 中国实用外科杂志, 2021, 41( 3): 241- 247. DOI: 10.19538/j.cjps.issn1005-2208.2021.03.01.
[12]	WANG CL, YANG Y, SUN DL, et al. Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis[J]. PLoS One, 2017, 12( 5): e0176827. DOI: 10.1371/journal.pone.0176827.
[13]	CHIBA M, AOKAWA M, GOTO T, et al. Peroral cholangioscopy for the evaluation of bile duct stricture in hepatocellular carcinoma on a preoperative examination[J]. J Rural Med, 2024, 19( 1): 44- 48. DOI: 10.2185/jrm.2023-022.
[14]	WU JY, HUANG LM, BAI YN, et al. Imaging features of hepatocellular carcinoma with bile duct tumor thrombus: A multicenter study[J]. Front Oncol, 2021, 11: 723455. DOI: 10.3389/fonc.2021.723455.
[15]	ZHOU X, WANG J, TANG M, et al. Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge[J]. BMC Cancer, 2020, 20( 1): 54. DOI: 10.1186/s12885-020-6539-7.
[16]	LU RJ, SUN FF, DU J, et al. Hepatocellular carcinoma with bile duct tumor thrombus: A case report[J]. J Clin Hepatol, 2022, 38( 8): 1872- 1874. DOI: 10.3969/j.issn.1001-5256.2022.08.028. 鲁人竭, 孙芳芳, 杜杰, 等. 肝细胞癌合并胆管癌栓1例报告[J]. 临床肝胆病杂志, 2022, 38( 8): 1872- 1874. DOI: 10.3969/j.issn.1001-5256.2022.08.028.
[17]	LU WP, TANG HW, YANG ZY, et al. A proposed modification for the Barcelona clinic liver cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma[J]. Am J Surg, 2020, 220( 4): 965- 971. DOI: 10.1016/j.amjsurg.2020.04.003.
[18]	FENG JK, WU YX, CHEN ZH, et al. The effect of bile duct tumor thrombus on the long-term prognosis of hepatocellular carcinoma patients after liver resection: A systematic review and meta-analysis[J]. Ann Transl Med, 2020, 8( 24): 1683. DOI: 10.21037/atm-20-4698.
[19]	FENG JK, CHEN ZH, WU YX, et al. Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: A systematic review and meta-analysis[J]. Ann Transl Med, 2020, 8( 23): 1567. DOI: 10.21037/atm-20-3935.
[20]	SHAN JJ, LI XC. Preoperative biliary drainage of hilar cholangiocarcinoma and its influence on safety of surgery[J/OL]. Chin J Hepat Surg(Electronic Edition), 2023, 12( 2): 157- 161. DOI: 10.3877/cma.j.issn.2095-3232.2023.02.007. 单季军, 李相成. 肝门部胆管癌术前减黄及其对手术安全性的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12( 2): 157- 161. DOI: 10.3877/cma.j.issn.2095-3232.2023.02.007.
[21]	LIN ZC, HAN MR, ZHOU Z. Prognosis for patients with hepatocellular carcinoma(HCC) with bile duct tumor thrombus(BDTT) after surgical treatment[J]. Biosci Trends, 2019, 13( 1): 77- 85. DOI: 10.5582/bst.2018.01234.
[22]	LIU ZH, SUN JX, FENG JK, et al. Prognostic comparison between liver resection and transcatheter arterial chemoembolization for hepatocellular carcinoma patients with bile duct tumor thrombus: A propensity-score matching analysis[J]. Front Oncol, 2022, 12: 835559. DOI: 10.3389/fonc.2022.835559.
[23]	CHOTIROSNIRAMIT A, LIWATTANAKUN A, JUNRUNGSEE S, et al. The benefit of curative liver resection with a selective bile duct preserving approach for hepatocellular carcinoma with macroscopic bile duct tumor thrombus[J]. Hepatobiliary Surg Nutr, 2020, 9( 6): 729- 738. DOI: 10.21037/hbsn.2019.10.26.
[24]	KIM DS, KIM BW, HATANO E, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: A Korea-Japan multicenter study[J]. Ann Surg, 2020, 271( 5): 913- 921. DOI: 10.1097/SLA.0000000000003014.
[25]	PHAM AT, DUC VU T, NGUYEN TD, et al. Surgical management for hepatocellular carcinoma with concurrent portal vein tumour thrombus and bile duct tumour thrombus: A case report[J]. Ann Med Surg(Lond), 2024, 86( 6): 3667- 3673. DOI: 10.1097/MS9.0000000000002035.
[26]	FENG JK, SUN JX, LIU ZH, et al. Efficacy and safety of transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma associated with bile duct tumor thrombus: A real-world retrospective cohort study[J]. Cancer Manag Res, 2021, 13: 3551- 3560. DOI: 10.2147/CMAR.S307065.
[27]	PENG QJ, DAI T, XIE GB, et al. Research advances in transcatheter arterial chemoembolization combined with targeted agents or anti-PD-1/PD-L1 monoclonal antibody in treatment of patients with unresectable hepatocellular carcinoma[J]. J Clin Hepatol, 2023, 39( 7): 1740- 1746. DOI: 10.3969/j.issn.1001-5256.2023.07.033. 彭秋菊, 戴涛, 谢贵波, 等. 不可切除肝细胞癌的经肝动脉化疗栓塞术联合靶向药物或程序性死亡受体1及其配体单抗治疗进展[J]. 临床肝胆病杂志, 2023, 39( 7): 1740- 1746. DOI: 10.3969/j.issn.1001-5256.2023.07.033.
[28]	LEE JS, KIM J, RHU J, et al. Long-term outcomes of liver transplantation in hepatocellular carcinoma with bile duct tumor thrombus: A comparison with portal vein tumor thrombus[J]. Cancers(Basel), 2023, 15( 17): 4225. DOI: 10.3390/cancers15174225.
[29]	National Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer(2024 edition)[J]. J Clin Hepatol, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508. 中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.
[30]	GORDAN JD, KENNEDY EB, ABOU-ALFA GK, et al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update[J]. J Clin Oncol, 2024, 42( 15): 1830- 1850. DOI: 10.1200/JCO.23.02745.
[31]	WU JY, SUN JX, WU JY, et al. Impact of bile duct tumor thrombus on the long-term surgical outcomes of hepatocellular carcinoma patients: A propensity score matching analysis[J]. Ann Surg Oncol, 2022, 29( 2): 949- 958. DOI: 10.1245/s10434-021-10799-0.
[32]	KIM JM, KWON CHD, JOH JW, et al. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: A matched study[J]. Medicine(Baltimore), 2015, 94( 6): e450. DOI: 10.1097/MD.0000000000000450.
[33]	RAMMOHAN A, SATHYANESAN J, RAJENDRAN K, et al. Bile duct thrombi in hepatocellular carcinoma: Is aggressive surgery worthwhile?[J]. HPB(Oxford), 2015, 17( 6): 508- 513. DOI: 10.1111/hpb.12383.
[34]	CHI QY, SHI Z, ZHANG ZB, et al. Outcomes of resection for hepatocellular carcinoma with macroscopic bile duct tumour thrombus: A propensity score matched study[J]. Oncol Lett, 2020, 20( 4): 118. DOI: 10.3892/ol.2020.11979.
[35]	SHIOMI M, KAMIYA J, NAGINO M, et al. Hepatocellular carcinoma with biliary tumor thrombi: Aggressive operative approach after appropriate preoperative management[J]. Surgery, 2001, 129( 6): 692- 698. DOI: 10.1067/msy.2001.113889.
[36]	HUANG LM, ZENG ZX, WU JY, et al. Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: A multicenter study[J]. Front Oncol, 2023, 13: 1291479. DOI: 10.3389/fonc.2023.1291479.
[37]	SUN JX, WU JY, SHI J, et al. Thrombus-first surgery for hepatocellular carcinoma with bile duct tumor thrombus[J]. J Gastrointest Surg, 2021, 25( 8): 1973- 1979. DOI: 10.1007/s11605-020-04813-1.
[38]	LI YN, WEI SM, FU YK, et al. Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: A propensity score matching analysis[J]. Front Oncol, 2024, 14: 1372123. DOI: 10.3389/fonc.2024.1372123.
[39]	XIANG YJ, SUN JX, WU JY, et al. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: A multicenter observational study[J]. HPB(Oxford), 2022, 24( 10): 1703- 1710. DOI: 10.1016/j.hpb.2022.04.007.

Relative Articles

[1]	Xiaoqin ZHU, Na WEI, Yong XIAO, Baoping YU. Impact of hepatocellular carcinoma on the prognosis of patients with liver cirrhosis undergoing emergency endoscopic therapy due to esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2025, 41(2): 277-283. doi: 10.12449/JCH250213
[2]	Yashu ZHOU, Yihui MA, Jiaxin PEI, Yuanyuan MENG, Peng GUO, Xiyue LIANG, Taiying LU. Clinical diagnosis， treatment， and prognosis of gallbladder sarcomatoid carcinoma： An analysis of 16 cases[J]. Journal of Clinical Hepatology, 2024, 40(4): 767-772. doi: 10.12449/JCH240420
[3]	Jiahao XU, Dongxu YIN, Yuchen LI, Fujie CHEN, Mingda WANG, Tian YANG. Systemic therapy for advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(11): 2306-2314. doi: 10.12449/JCH241127
[4]	Yuan DUAN, Ting ZHANG, Jing ZHANG, Guiwen GUAN, Jingzhou WANG, Xiangmei CHEN. Expression of AU-rich element RNA-binding factor 1 in hepatocellular carcinoma and its value in prognostic evaluation[J]. Journal of Clinical Hepatology, 2024, 40(9): 1833-1839. doi: 10.12449/JCH240918
[5]	Zheng SONG, Wei LUO, Xiujuan CHANG, Yongping YANG. Construction of a novel disulfidptosis-related prognostic model for patients with hepatocellular carcinoma based on bioinformatics analysis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1822-1832. doi: 10.12449/JCH240917
[6]	Jun LIU, Ling WANG, Yuhuan JIANG, Jingzhi WANG, Huiming LI. Establishment of a risk model based on immunogenic cell death-related genes and its value in predicting the prognosis and tumor microenvironment characteristics of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(12): 2473-2483. doi: 10.12449/JCH241218
[7]	Tingting SHI, Runbing ZHANG, Yang WU, Yani ZHANG, Lingling ZHU, Chun GAO, Jingjing JIANG, Xiaofeng ZHENG, Jiucong ZHANG. Role of extracellular vesicles of different origins in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(6): 1264-1268. doi: 10.12449/JCH240630
[8]	Meng REN, Yi YANG, Ziming LI, Renqian ZHANG, Yufeng SHI, Junxiu TAO. Clinical features and prognosis of hepatocellular carcinoma： A single-center study of 850 cases[J]. Journal of Clinical Hepatology, 2024, 40(10): 2019-2026. doi: 10.12449/JCH241015
[9]	Yi LE, Hao YANG, Hu LIU, Zhaoyang CUI, Xiangning ZHAO, Liang AN, Haizhu LI, Shaogeng ZHANG. Advances in the diagnosis and treatment of gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2738-2744. doi: 10.3969/j.issn.1001-5256.2023.11.032
[10]	Zhiying LIU, Zhihang ZHOU, Song HE. Research advances in the role of blood metabolic markers in the treatment response and prognosis prediction of primary liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(10): 2470-2475. doi: 10.3969/j.issn.1001-5256.2023.10.028
[11]	Liver Oncology Branch, China Association for the Promotion of International Exchange in Healthcare, Immunology Branch. Chinese expert consensus on targeted immunotherapy combined with local therapy for advanced hepatocellular cancer[J]. Journal of Clinical Hepatology, 2023, 39(12): 2782-2792. doi: 10.3969/j.issn.1001-5256.2023.12.006
[12]	Yuyan TANG, Shibin XIE, Jianyun ZHU. Diagnostic efficacy of alpha-fetoprotein and alpha-fetoprotein L3% in hepatitis B virus-related early-stage hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2607-2613. doi: 10.3969/j.issn.1001-5256.2023.11.014
[13]	Kechun WANG, Mingda WANG, Tian YANG. Key points in AASLD Practice Guidance on Prevention， Diagnosis， and Treatment of Hepatocellular Carcinoma （2023）[J]. Journal of Clinical Hepatology, 2023, 39(9): 2081-2086. doi: 10.3969/j.issn.1001-5256.2023.09.008
[14]	Renjie LU, Fangfang SUN, Jie DU, Lirong ZHAO. Hepatocellular carcinoma with bile duct tumor thrombus: A case report[J]. Journal of Clinical Hepatology, 2022, 38(8): 1872-1874. doi: 10.3969/j.issn.1001-5256.2022.08.028
[15]	Shiyan YAN, Jiangao FAN. Diagnosis and treatment of hepatocellular carcinoma associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(8): 1748-1752. doi: 10.3969/j.issn.1001-5256.2021.08.002
[16]	Hang DING, Linlin ZHENG, Yuan LIU, Lianfeng ZHANG, Lin ZHOU. Clinical features and prognosis of autoimmune pancreatitis alone or with IgG4-related sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2021, 37(4): 888-892. doi: 10.3969/j.issn.1001-5256.2021.04.032
[17]	Dang FuTao, Tang YingMei. Diagnostic and prognostic value of autoantibodies in primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(5): 1164-1166. doi: 10.3969/j.issn.1001-5256.2020.05.048
[18]	Luo Qiong, Wang ChunMing, Liao HangYu, Chen KunLing, Pan MingXin. Value of the NDRG family in the diagnosis and prognostic evaluation of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(6): 1284-1288. doi: 10.3969/j.issn.1001-5256.2020.06.019
[19]	Hu MuRen, Ge BuJun. Source of portal vein tumor thrombosis and advances in its diagnosis and treatment[J]. Journal of Clinical Hepatology, 2018, 34(10): 2069-2075. doi: 10.3969/j.issn.1001-5256.2018.10.006
[20]	Su LiHong, Zhu XinYu, Zhang LiaoYun. Diagnosis strategies for intrahepatic cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2017, 33(1): 180-183. doi: 10.3969/j.issn.1001-5256.2017.01.042

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (72) PDF downloads(14)

Advances in the diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus

DOI: 10.12449/JCH250224

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Advances in the diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus

DOI: 10.12449/JCH250224

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content